Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-type voltage-gated calcium channels are a class of low-voltage-activated (LVA) ion channels that permit the influx of calcium ions (Ca²⁺) into excitable and some non-excitable cells in response to small depolarizations of the cell membrane. The "T" stands for "transient," reflecting their rapid activation and inactivation kinetics. There are three main isoforms: CaV3.1 (CACNA1G), CaV3.2 (CACNA1H), and CaV3.3 (CACNA1I). They play crucial roles in pacemaking, neuronal excitability, hormone secretion, and smooth muscle contraction. Dysfunction is implicated in epilepsy, neuropathic pain, cardiac arrhythmias, and hypertension. Mibefradil and Ni²⁺ are known blockers.
T-type calcium channel blockade
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-type Voltage-Gated Calcium Channel.